MRNA
Income statement / Annual
Last year (2023), Moderna, Inc.'s total revenue was $6.85 B,
a decrease of 64.45% from the previous year.
In 2023, Moderna, Inc.'s net income was -$4.71 B.
See Moderna, Inc.’s key income statements, including revenue, expenses, profit, and income.
| Period |
FY-2023
|
FY-2022
|
FY-2021
|
FY-2020
|
FY-2019
|
FY-2018
|
FY-2017
|
FY-2016
|
| Period Ended |
12/31/2023 |
12/31/2022 |
12/31/2021 |
12/31/2020 |
12/31/2019 |
12/31/2018 |
12/31/2017 |
12/31/2016 |
| Operating Revenue |
$6.85 B
|
$19.26 B
|
$17.74 B
|
$274.49 M
|
$48.04 M
|
$122.51 M
|
$176.97 M
|
$101.54 M
|
| Cost of Revenue |
$4.69 B |
$5.42 B |
$2.62 B |
$7.93 M |
$31.02 M |
$454.08 M |
$20.54 M |
$15.11 M |
| Gross Profit |
$2.16 B |
$13.85 B |
$15.12 B |
$266.56 M |
$17.02 M |
-$331.57 M |
$156.44 M |
$86.42 M |
| Gross Profit Ratio |
0.31 |
0.72 |
0.85 |
0.97 |
0.35 |
-2.71 |
0.88 |
0.85 |
| Research and Development
Expenses |
$4.85 B
|
$3.30 B
|
$1.99 B
|
$1.37 B
|
$496.31 M
|
$454.08 M
|
$410.46 M
|
$274.72 M
|
| General & Administrative
Expenses |
$1.35 B
|
$1.01 B
|
$0.00
|
$0.00
|
$109.62 M
|
$94.25 M
|
$64.72 M
|
$57.45 M
|
| Selling & Marketing
Expenses |
$204.00 M
|
$121.00 M
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
| Selling, General &
Administrative Expenses |
$1.55 B
|
$1.13 B
|
$567.00 M
|
$188.27 M
|
$109.62 M
|
$94.25 M
|
$64.72 M
|
$57.45 M
|
| Other Expenses |
$0.00 |
-$45.00 M |
-$735.00 M |
-$528.91 M |
$0.00 |
-$12.56 M |
-$28.85 M |
-$2.71 M |
| Operating Expenses |
$6.39 B |
$4.43 B |
$1.82 B |
$1.03 B |
$593.76 M |
$535.78 M |
$446.33 M |
$325.31 M |
| Cost And Expenses |
$11.09 B |
$9.84 B |
$4.44 B |
$1.04 B |
$593.76 M |
$535.78 M |
$446.33 M |
$325.31 M |
| Interest Income |
$421.00 M |
$200.00 M |
$18.00 M |
$24.72 M |
$38.53 M |
$27.02 M |
$15.24 M |
$11.31 M |
| Interest Expense |
$38.00 M |
$29.00 M |
$18.00 M |
$9.89 M |
$6.61 M |
$3.10 M |
$132,000.00 |
$0.00 |
| Depreciation &
Amortization |
$621.00 M
|
$348.00 M
|
$232.00 M
|
$31.25 M
|
$31.02 M
|
$24.86 M
|
$20.54 M
|
$15.11 M
|
| EBITDA |
-$3.28 B
|
$9.77 B
|
$13.53 B
|
-$732.00 M
|
-$515.00 M
|
-$388.40 M
|
-$235.33 M
|
-$208.66 M
|
| EBITDA Ratio |
-0.48 |
0.51 |
0.75 |
-2.78 |
-11.36 |
-3.37 |
-1.41 |
-2.06 |
| Operating Income Ratio
|
-0.62
|
0.49
|
0.75
|
-2.78
|
-11.36
|
-3.37
|
-1.52
|
-2.2
|
| Total Other
Income/Expenses Net |
$297.00 M
|
$155.00 M
|
-$11.00 M
|
$18.63 M
|
$31.00 M
|
$28.86 M
|
$13.36 M
|
$8.60 M
|
| Income Before Tax |
-$3.94 B |
$9.58 B |
$13.29 B |
-$744.51 M |
-$514.72 M |
-$384.41 M |
-$256.00 M |
-$215.17 M |
| Income Before Tax Ratio
|
-0.58
|
0.5
|
0.75
|
-2.71
|
-10.72
|
-3.14
|
-1.45
|
-2.12
|
| Income Tax Expense |
$772.00 M |
$1.21 B |
$1.08 B |
$2.55 M |
-$695,000.00 |
$326,000.00 |
-$80,000.00 |
$1.04 M |
| Net Income |
-$4.71 B |
$8.36 B |
$12.20 B |
-$747.06 M |
-$514.02 M |
-$384.73 M |
-$255.92 M |
-$216.21 M |
| Net Income Ratio |
-0.69 |
0.43 |
0.69 |
-2.72 |
-10.7 |
-3.14 |
-1.45 |
-2.13 |
| EPS |
-12.34 |
21.22 |
30.28 |
-1.96 |
-1.55 |
-4.74 |
-0.68 |
-0.58 |
| EPS Diluted |
-12.34 |
20.1 |
28.31 |
-1.96 |
-1.55 |
-4.74 |
-0.68 |
-0.58 |
| Weighted Average Shares
Out |
$382.00 M
|
$394.00 M
|
$403.00 M
|
$381.33 M
|
$330.80 M
|
$81.11 M
|
$376.00 M
|
$376.00 M
|
| Weighted Average Shares
Out Diluted |
$382.00 M
|
$416.00 M
|
$431.00 M
|
$381.33 M
|
$330.80 M
|
$81.11 M
|
$376.00 M
|
$376.00 M
|
| Link |
|
|
|
|
|
|
|
|
